Severe Bleeding
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New Antidots (NCT03537521) | Cardioangiologisches Centrum Bethanien | 2020-04-01 |
| Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (NCT01722786) | Cardioangiologisches Centrum Bethanien | 2014-04-01 |
Track Severe Bleeding automatically
Every clearance here is in the API, with alerts when new ones post.